ID   FOLR1_HUMAN             Reviewed;         257 AA.
AC   P15328; Q53EW2; Q6FGT8; Q6LC90; Q9UCT2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 3.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Folate receptor alpha;
DE            Short=FR-alpha;
DE   AltName: Full=Adult folate-binding protein;
DE            Short=FBP;
DE   AltName: Full=Folate receptor 1;
DE   AltName: Full=Folate receptor, adult;
DE   AltName: Full=KB cells FBP;
DE   AltName: Full=Ovarian tumor-associated antigen MOv18;
DE   Flags: Precursor;
GN   Name=FOLR1; Synonyms=FOLR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=2768245;
RA   Elwood P.C.;
RT   "Molecular cloning and characterization of the human folate-binding
RT   protein cDNA from placenta and malignant tissue culture (KB) cells.";
RL   J. Biol. Chem. 264:14893-14901(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=2527252; DOI=10.1172/JCI114220;
RA   Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G.W., Kamen B.A.;
RT   "Complementary DNA for the folate binding protein correctly predicts
RT   anchoring to the membrane by glycosyl-phosphatidylinositol.";
RL   J. Clin. Invest. 84:715-720(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ovary;
RX   PubMed=1717147;
RA   Campbell I.G., Jones T.A., Foulkes W.D., Trowsdale J.;
RT   "Folate-binding protein is a marker for ovarian cancer.";
RL   Cancer Res. 51:5329-5338(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 31-56.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=1840502;
RA   Coney L.R., Tomassetti A., Carayannopoulos L., Frasca V., Kamen B.A.,
RA   Colnaghi M.I., Zurawski V.R. Jr.;
RT   "Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies
RT   recognize a folate-binding protein.";
RL   Cancer Res. 51:6125-6132(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1581364; DOI=10.1016/0167-4781(92)90103-7;
RA   Sadasivan E., Cedeno M., Rothenberg S.P.;
RT   "Genomic organization of the gene and a related pseudogene for a human
RT   folate binding protein.";
RL   Biochim. Biophys. Acta 1131:91-94(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], NUCLEOTIDE SEQUENCE [MRNA] OF 1-56,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Lymphocyte;
RX   PubMed=9063895; DOI=10.1021/bi962070h;
RA   Elwood P.C., Nachmanoff K., Saikawa Y., Page S.T., Pacheco P.,
RA   Roberts S., Chung K.-N.;
RT   "The divergent 5' termini of the alpha human folate receptor (hFR)
RT   mRNAs originate from two tissue-specific promoters and alternative
RT   splicing: characterization of the alpha hFR gene structure.";
RL   Biochemistry 36:1467-1478(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney proximal tubule;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-249.
RX   PubMed=2538429;
RA   Sadasivan E., Rothenberg S.P.;
RT   "The complete amino acid sequence of a human folate binding protein
RT   from KB cells determined from the cDNA.";
RL   J. Biol. Chem. 264:5806-5811(1989).
RN   [13]
RP   PROTEIN SEQUENCE OF 26-43, AND SUBCELLULAR LOCATION.
RX   PubMed=3476960; DOI=10.1073/pnas.84.18.6546;
RA   Luhrs C.A., Pitiranggon P., da Costa M., Rothenberg S.P.,
RA   Slomiany B.L., Brink L., Tous G.I., Stein S.;
RT   "Purified membrane and soluble folate binding proteins from cultured
RT   KB cells have similar amino acid compositions and molecular weights
RT   but differ in fatty acid acylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6546-6549(1987).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8033114;
RA   Orr R.B., Kamen B.A.;
RT   "UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a
RT   mutant nonfunctional folate receptor.";
RL   Cancer Res. 54:3905-3911(1994).
RN   [15]
RP   GPI-ANCHOR AT SER-234, AND SUBCELLULAR LOCATION.
RX   PubMed=7578066; DOI=10.1021/bi00044a039;
RA   Yan W., Ratnam M.;
RT   "Preferred sites of glycosylphosphatidylinositol modification in
RT   folate receptors and constraints in the primary structure of the
RT   hydrophobic portion of the signal.";
RL   Biochemistry 34:14594-14600(1995).
RN   [16]
RP   FUNCTION, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=8567728; DOI=10.1083/jcb.132.1.35;
RA   Rijnboutt S., Jansen G., Posthuma G., Hynes J.B., Schornagel J.H.,
RA   Strous G.J.;
RT   "Endocytosis of GPI-linked membrane folate receptor-alpha.";
RL   J. Cell Biol. 132:35-47(1996).
RN   [17]
RP   GPI-ANCHOR [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=14517339; DOI=10.1074/mcp.M300079-MCP200;
RA   Elortza F., Nuehse T.S., Foster L.J., Stensballe A., Peck S.C.,
RA   Jensen O.N.;
RT   "Proteomic analysis of glycosylphosphatidylinositol-anchored membrane
RT   proteins.";
RL   Mol. Cell. Proteomics 2:1261-1270(2003).
RN   [18]
RP   GPI-ANCHOR [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16602701; DOI=10.1021/pr050419u;
RA   Elortza F., Mohammed S., Bunkenborg J., Foster L.J., Nuehse T.S.,
RA   Brodbeck U., Peck S.C., Jensen O.N.;
RT   "Modification-specific proteomics of plasma membrane proteins:
RT   identification and characterization of glycosylphosphatidylinositol-
RT   anchored proteins released upon phospholipase D treatment.";
RL   J. Proteome Res. 5:935-943(2006).
RN   [19]
RP   GPI-ANCHOR AT SER-234, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17566972; DOI=10.1002/pmic.200700068;
RA   Omaetxebarria M.J., Elortza F., Rodriguez-Suarez E., Aloria K.,
RA   Arizmendi J.M., Jensen O.N., Matthiesen R.;
RT   "Computational approach for identification and characterization of
RT   GPI-anchored peptides in proteomics experiments.";
RL   Proteomics 7:1951-1960(2007).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-161 AND ASN-201.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [21]
RP   INVOLVEMENT IN NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT
RP   DEFICIENCY.
RX   PubMed=19732866; DOI=10.1016/j.ajhg.2009.08.005;
RA   Steinfeld R., Grapp M., Kraetzner R., Dreha-Kulaczewski S., Helms G.,
RA   Dechent P., Wevers R., Grosso S., Gaertner J.;
RT   "Folate receptor alpha defect causes cerebral folate transport
RT   deficiency: a treatable neurodegenerative disorder associated with
RT   disturbed myelin metabolism.";
RL   Am. J. Hum. Genet. 85:354-363(2009).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 23-235 IN COMPLEX WITH
RP   FOLATE, FUNCTION, MUTAGENESIS OF TYR-82; ASP-103; TYR-107; TRP-124;
RP   ARG-125; ARG-128; HIS-157; TRP-162 AND SER-196, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-69; ASN-161 AND ASN-201.
RX   PubMed=23851396; DOI=10.1038/nature12327;
RA   Chen C., Ke J., Zhou X.E., Yi W., Brunzelle J.S., Li J., Yong E.L.,
RA   Xu H.E., Melcher K.;
RT   "Structural basis for molecular recognition of folic acid by folate
RT   receptors.";
RL   Nature 500:486-489(2013).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 30-234, FUNCTION,
RP   GLYCOSYLATION AT ASN-69; ASN-161 AND ASN-201, AND DISULFIDE BONDS.
RX   PubMed=23934049; DOI=10.1073/pnas.1308827110;
RA   Wibowo A.S., Singh M., Reeder K.M., Carter J.J., Kovach A.R., Meng W.,
RA   Ratnam M., Zhang F., Dann C.E. III;
RT   "Structures of human folate receptors reveal biological trafficking
RT   states and diversity in folate and antifolate recognition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:15180-15188(2013).
CC   -!- FUNCTION: Binds to folate and reduced folic acid derivatives and
CC       mediates delivery of 5-methyltetrahydrofolate and folate analogs
CC       into the interior of cells. Has high affinity for folate and folic
CC       acid analogs at neutral pH. Exposure to slightly acidic pH after
CC       receptor endocytosis triggers a conformation change that strongly
CC       reduces its affinity for folates and mediates their release.
CC       Required for normal embryonic development and normal cell
CC       proliferation. {ECO:0000269|PubMed:23851396,
CC       ECO:0000269|PubMed:23934049, ECO:0000269|PubMed:2527252,
CC       ECO:0000269|PubMed:8033114, ECO:0000269|PubMed:8567728}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
CC       Secreted {ECO:0000305}. Cytoplasmic vesicle. Cytoplasmic vesicle,
CC       clathrin-coated vesicle. Endosome. Apical cell membrane
CC       {ECO:0000250}. Note=Endocytosed into cytoplasmic vesicles and then
CC       recycled to the cell membrane.
CC   -!- TISSUE SPECIFICITY: Primarily expressed in tissues of epithelial
CC       origin. Expression is increased in malignant tissues. Expressed in
CC       kidney, lung and cerebellum. Detected in placenta and thymus
CC       epithelium. {ECO:0000269|PubMed:2527252,
CC       ECO:0000269|PubMed:2768245, ECO:0000269|PubMed:9063895}.
CC   -!- PTM: The secreted form is derived from the membrane-bound form
CC       either by cleavage of the GPI anchor, or/and by proteolysis
CC       catalyzed by a metalloprotease.
CC   -!- DISEASE: Neurodegeneration due to cerebral folate transport
CC       deficiency (NCFTD) [MIM:613068]: A neurodegenerative disorder
CC       resulting from brain-specific folate deficiency early in life.
CC       Onset is apparent in late infancy with severe developmental
CC       regression, movement disturbances, epilepsy and leukodystrophy.
CC       {ECO:0000269|PubMed:19732866}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the folate receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05013; AAA35823.1; -; mRNA.
DR   EMBL; M28099; AAA35822.1; -; mRNA.
DR   EMBL; X62753; CAA44610.1; -; mRNA.
DR   EMBL; U20391; AAB05827.1; -; Genomic_DNA.
DR   EMBL; U78793; AAB39751.1; -; mRNA.
DR   EMBL; U78794; AAB39752.1; -; mRNA.
DR   EMBL; BT007158; AAP35822.1; -; mRNA.
DR   EMBL; CR542019; CAG46816.1; -; mRNA.
DR   EMBL; AK223527; BAD97247.1; -; mRNA.
DR   EMBL; CH471076; EAW74848.1; -; Genomic_DNA.
DR   EMBL; BC002947; AAH02947.1; -; mRNA.
DR   EMBL; M25317; AAA74896.1; -; mRNA.
DR   CCDS; CCDS8211.1; -.
DR   PIR; A44904; A45753.
DR   RefSeq; NP_000793.1; NM_000802.3.
DR   RefSeq; NP_057936.1; NM_016724.2.
DR   RefSeq; NP_057937.1; NM_016725.2.
DR   RefSeq; NP_057941.1; NM_016729.2.
DR   UniGene; Hs.73769; -.
DR   PDB; 4KM6; X-ray; 1.55 A; A=30-234.
DR   PDB; 4KM7; X-ray; 1.80 A; A/B=28-234.
DR   PDB; 4KMX; X-ray; 2.20 A; A=28-234.
DR   PDB; 4LRH; X-ray; 2.80 A; A/B/C/D/E/F/G/H=23-235.
DR   PDB; 5IZQ; X-ray; 3.60 A; A/B/C/D/E/F/G/H=1-235.
DR   PDBsum; 4KM6; -.
DR   PDBsum; 4KM7; -.
DR   PDBsum; 4KMX; -.
DR   PDBsum; 4LRH; -.
DR   PDBsum; 5IZQ; -.
DR   ProteinModelPortal; P15328; -.
DR   SMR; P15328; -.
DR   BioGrid; 108631; 13.
DR   IntAct; P15328; 11.
DR   STRING; 9606.ENSP00000308137; -.
DR   BindingDB; P15328; -.
DR   ChEMBL; CHEMBL2121; -.
DR   DrugBank; DB05168; EC145.
DR   DrugBank; DB05595; Farletuzumab.
DR   DrugBank; DB00563; Methotrexate.
DR   TCDB; 9.B.92.1.1; the folate receptor (fr) family.
DR   BioMuta; FOLR1; -.
DR   DMDM; 544337; -.
DR   EPD; P15328; -.
DR   MaxQB; P15328; -.
DR   PaxDb; P15328; -.
DR   PeptideAtlas; P15328; -.
DR   PRIDE; P15328; -.
DR   DNASU; 2348; -.
DR   Ensembl; ENST00000312293; ENSP00000308137; ENSG00000110195.
DR   Ensembl; ENST00000393676; ENSP00000377281; ENSG00000110195.
DR   Ensembl; ENST00000393679; ENSP00000377284; ENSG00000110195.
DR   Ensembl; ENST00000393681; ENSP00000377286; ENSG00000110195.
DR   GeneID; 2348; -.
DR   KEGG; hsa:2348; -.
DR   UCSC; uc001orz.3; human.
DR   CTD; 2348; -.
DR   DisGeNET; 2348; -.
DR   GeneCards; FOLR1; -.
DR   HGNC; HGNC:3791; FOLR1.
DR   HPA; HPA077030; -.
DR   MalaCards; FOLR1; -.
DR   MIM; 136430; gene.
DR   MIM; 613068; phenotype.
DR   neXtProt; NX_P15328; -.
DR   OpenTargets; ENSG00000110195; -.
DR   Orphanet; 217382; Neurodegenerative syndrome due to cerebral folate transport deficiency.
DR   PharmGKB; PA28207; -.
DR   eggNOG; ENOG410IFFP; Eukaryota.
DR   eggNOG; ENOG4111IU4; LUCA.
DR   GeneTree; ENSGT00390000010470; -.
DR   HOGENOM; HOG000006539; -.
DR   HOVERGEN; HBG039612; -.
DR   InParanoid; P15328; -.
DR   KO; K13649; -.
DR   OMA; NWTSGFN; -.
DR   OrthoDB; EOG091G0GIA; -.
DR   PhylomeDB; P15328; -.
DR   TreeFam; TF328532; -.
DR   Reactome; R-HSA-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   GeneWiki; Folate_receptor_1; -.
DR   GenomeRNAi; 2348; -.
DR   PRO; PR:P15328; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110195; -.
DR   CleanEx; HS_FOLR1; -.
DR   ExpressionAtlas; P15328; baseline and differential.
DR   Genevisible; P15328; HS.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0005886; C:plasma membrane; NAS:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IPI:BHF-UCL.
DR   GO; GO:0005542; F:folic acid binding; IDA:UniProtKB.
DR   GO; GO:0061714; F:folic acid receptor activity; IC:BHF-UCL.
DR   GO; GO:0008517; F:folic acid transporter activity; IMP:UniProtKB.
DR   GO; GO:0051870; F:methotrexate binding; IDA:BHF-UCL.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0061713; P:anterior neural tube closure; ISS:BHF-UCL.
DR   GO; GO:0031103; P:axon regeneration; ISS:BHF-UCL.
DR   GO; GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0071231; P:cellular response to folic acid; IDA:BHF-UCL.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0046655; P:folic acid metabolic process; IEA:Ensembl.
DR   GO; GO:0015884; P:folic acid transport; IMP:UniProtKB.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0003147; P:neural crest cell migration involved in heart formation; ISS:BHF-UCL.
DR   GO; GO:0061626; P:pharyngeal arch artery morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL.
DR   InterPro; IPR004269; Folate_rcpt.
DR   InterPro; IPR018143; Folate_rcpt-like.
DR   InterPro; IPR032935; FOLR1.
DR   PANTHER; PTHR10517; PTHR10517; 1.
DR   PANTHER; PTHR10517:SF33; PTHR10517:SF33; 1.
DR   Pfam; PF03024; Folate_rec; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Endosome; Folate-binding;
KW   Glycoprotein; GPI-anchor; Lipoprotein; Membrane; Neurodegeneration;
KW   Polymorphism; Receptor; Reference proteome; Secreted; Signal;
KW   Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    234       Folate receptor alpha.
FT                                /FTId=PRO_0000008802.
FT   PROPEP      235    257       Removed in mature form.
FT                                /FTId=PRO_0000008803.
FT   REGION      124    128       Folate binding.
FT                                {ECO:0000269|PubMed:23851396}.
FT   REGION      157    162       Folate binding.
FT                                {ECO:0000269|PubMed:23851396}.
FT   BINDING     103    103       Folate. {ECO:0000269|PubMed:23851396}.
FT   BINDING     107    107       Folate. {ECO:0000269|PubMed:23851396}.
FT   BINDING     196    196       Folate. {ECO:0000269|PubMed:23851396}.
FT   LIPID       234    234       GPI-anchor amidated serine.
FT                                {ECO:0000269|PubMed:17566972,
FT                                ECO:0000269|PubMed:7578066}.
FT   CARBOHYD     69     69       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     37     65       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     57    105       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     66    109       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     89    175       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID     96    146       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    135    209       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    139    189       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   DISULFID    152    169       {ECO:0000244|PDB:4KM6,
FT                                ECO:0000244|PDB:4KM7,
FT                                ECO:0000244|PDB:4KMX,
FT                                ECO:0000244|PDB:4LRH,
FT                                ECO:0000269|PubMed:23851396,
FT                                ECO:0000269|PubMed:23934049}.
FT   VARIANT      28     28       W -> R (in dbSNP:rs7928649).
FT                                /FTId=VAR_059284.
FT   VARIANT     160    160       W -> C (in dbSNP:rs1801932).
FT                                /FTId=VAR_011963.
FT   MUTAGEN      82     82       Y->A: Slightly reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     103    103       D->A: Strongly reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     107    107       Y->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     124    124       W->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     125    125       R->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     128    128       R->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     157    157       H->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     162    162       W->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   MUTAGEN     196    196       S->A: Moderately reduced affinity for
FT                                folate. {ECO:0000269|PubMed:23851396}.
FT   CONFLICT    180    180       F -> L (in Ref. 9; BAD97247).
FT                                {ECO:0000305}.
FT   CONFLICT    184    184       T -> S (in Ref. 12; AAA74896).
FT                                {ECO:0000305}.
FT   HELIX        31     33       {ECO:0000244|PDB:4KMX}.
FT   STRAND       48     50       {ECO:0000244|PDB:4KM6}.
FT   TURN         53     56       {ECO:0000244|PDB:4KM6}.
FT   HELIX        58     60       {ECO:0000244|PDB:4KM6}.
FT   STRAND       63     67       {ECO:0000244|PDB:4KM6}.
FT   HELIX        68     73       {ECO:0000244|PDB:4LRH}.
FT   TURN         81     83       {ECO:0000244|PDB:4KM6}.
FT   TURN         86     89       {ECO:0000244|PDB:4KM6}.
FT   HELIX        94    109       {ECO:0000244|PDB:4KM6}.
FT   HELIX       114    116       {ECO:0000244|PDB:4KM6}.
FT   STRAND      117    122       {ECO:0000244|PDB:4LRH}.
FT   STRAND      124    126       {ECO:0000244|PDB:4KM6}.
FT   HELIX       136    145       {ECO:0000244|PDB:4KM6}.
FT   TURN        146    148       {ECO:0000244|PDB:4KM6}.
FT   STRAND      150    152       {ECO:0000244|PDB:4KM6}.
FT   STRAND      156    158       {ECO:0000244|PDB:4LRH}.
FT   HELIX       172    174       {ECO:0000244|PDB:4LRH}.
FT   HELIX       178    181       {ECO:0000244|PDB:4KM6}.
FT   HELIX       185    191       {ECO:0000244|PDB:4KM6}.
FT   TURN        192    195       {ECO:0000244|PDB:4KM6}.
FT   STRAND      206    210       {ECO:0000244|PDB:4KM6}.
FT   HELIX       216    218       {ECO:0000244|PDB:4KM6}.
FT   HELIX       222    232       {ECO:0000244|PDB:4KM6}.
SQ   SEQUENCE   257 AA;  29819 MW;  D458D8BB047C96A6 CRC64;
     MAQRMTTQLL LLLVWVAVVG EAQTRIAWAR TELLNVCMNA KHHKEKPGPE DKLHEQCRPW
     RKNACCSTNT SQEAHKDVSY LYRFNWNHCG EMAPACKRHF IQDTCLYECS PNLGPWIQQV
     DQSWRKERVL NVPLCKEDCE QWWEDCRTSY TCKSNWHKGW NWTSGFNKCA VGAACQPFHF
     YFPTPTVLCN EIWTHSYKVS NYSRGSGRCI QMWFDPAQGN PNEEVARFYA AAMSGAGPWA
     AWPFLLSLAL MLLWLLS
//
